DrugNewsWire

Hopefully we will all have less needles to take in the arm in the near future. A new universal vaccine that is effective against several strains of the flu has passed an initial phase of testing by researchers at the University of Texas at Galveston.

A universal vaccine could do a lot for the world and save billions in needles and serums. It is being developed by Dr.Turley at the Sealy Center for Vaccine development. It could also delay the onset of a pandemic by slowing down the mutations of A viruses in to more virulent forms. The researchers claim that it is a safe and highly effective way to prevent seasonal and pandemic influenza strains.

This study is well funded by a $9.5 million grant that was awarded to UTMB by the Bill & Melinda Gates Foundation.

The experimental drug trial was performed on sixy young adults in a double blind study that escalated the dose for the first time in humans. It was conducted to see if a response could be triggered in the immune system to the presence of the vaccine.

The trial was also designed to evaluate the methods of companies like VaxInnate (which is the delivery system used for this particular vaccine) to develop and produce healing modalities effectifely.

The company VaxInnate uses a proprietary combination of toll-like receptor-mediated immune enhancement and recombinant bacterial production of vaccine antigen to deliver the universal protective dose; if this technology is successful it could significantly reduce the amount of time that it takes to manufacture needles and also distribute them. This is crucial in the case of a pandemic. The concern that there would not be enough vaccine to go around has always been an issue with the media, public and the medical industries. It may be that innovative and cheap vaccination delivery systems are the answer as is the development of universal vaccines such as this one. This way people receive multiple protective benefits in one shot.